Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 15 studies | 42% ± 19% | |
epithelial cell | 15 studies | 38% ± 15% | |
plasma cell | 14 studies | 34% ± 12% | |
type I pneumocyte | 10 studies | 44% ± 15% | |
club cell | 9 studies | 33% ± 15% | |
secretory cell | 7 studies | 39% ± 17% | |
type II pneumocyte | 6 studies | 31% ± 15% | |
respiratory goblet cell | 6 studies | 30% ± 11% | |
IgA plasma cell | 5 studies | 23% ± 4% | |
IgG plasma cell | 5 studies | 27% ± 5% | |
ciliated cell | 5 studies | 32% ± 14% | |
goblet cell | 5 studies | 24% ± 7% | |
squamous epithelial cell | 4 studies | 57% ± 16% | |
abnormal cell | 4 studies | 22% ± 2% | |
hepatocyte | 4 studies | 52% ± 19% | |
hillock cell | 3 studies | 49% ± 7% | |
ionocyte | 3 studies | 23% ± 3% | |
epithelial cell of proximal tubule | 3 studies | 18% ± 2% | |
kidney loop of Henle epithelial cell | 3 studies | 33% ± 6% | |
transit amplifying cell | 3 studies | 34% ± 20% | |
keratinocyte | 3 studies | 38% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 37227.81 | 226 / 226 | 99% | 609.09 | 401 / 406 |
lung | 70% | 5966.88 | 407 / 578 | 95% | 736.72 | 1100 / 1155 |
kidney | 97% | 13038.13 | 86 / 89 | 64% | 184.62 | 581 / 901 |
bladder | 52% | 15447.57 | 11 / 21 | 95% | 1010.21 | 480 / 504 |
intestine | 38% | 3964.12 | 365 / 966 | 95% | 296.09 | 499 / 527 |
esophagus | 39% | 22613.36 | 558 / 1445 | 93% | 625.11 | 171 / 183 |
stomach | 40% | 2863.44 | 145 / 359 | 86% | 247.44 | 247 / 286 |
prostate | 70% | 8196.00 | 171 / 245 | 41% | 74.42 | 208 / 502 |
breast | 19% | 1101.72 | 89 / 459 | 90% | 400.25 | 1004 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 100% | 945.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 563.52 | 1 / 1 |
pancreas | 3% | 175.19 | 11 / 328 | 92% | 458.61 | 163 / 178 |
uterus | 2% | 676.94 | 4 / 170 | 88% | 828.55 | 406 / 459 |
skin | 72% | 41103.55 | 1302 / 1809 | 15% | 52.97 | 71 / 472 |
thymus | 9% | 424.58 | 56 / 653 | 70% | 136.38 | 425 / 605 |
adrenal gland | 21% | 1056.36 | 53 / 258 | 16% | 38.36 | 36 / 230 |
spleen | 26% | 1624.07 | 62 / 241 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 22% | 37.94 | 93 / 430 |
peripheral blood | 2% | 147.22 | 20 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 16.34 | 10 / 2642 | 2% | 3.09 | 11 / 705 |
adipose | 1% | 62.22 | 11 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 22.94 | 2 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 11.73 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0001657 | Biological process | ureteric bud development |
GO_0060009 | Biological process | Sertoli cell development |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0051591 | Biological process | response to cAMP |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0055002 | Biological process | striated muscle cell development |
GO_0048627 | Biological process | myoblast development |
GO_0009636 | Biological process | response to toxic substance |
GO_1903553 | Biological process | positive regulation of extracellular exosome assembly |
GO_0051592 | Biological process | response to calcium ion |
GO_0016477 | Biological process | cell migration |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0009986 | Cellular component | cell surface |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SDC1 |
Protein name | Syndecan 1 Syndecan-1 (SYND1) (CD antigen CD138) |
Synonyms | SDC |
Description | FUNCTION: Cell surface proteoglycan that contains both heparan sulfate and chondroitin sulfate and that links the cytoskeleton to the interstitial matrix (By similarity). Regulates exosome biogenesis in concert with SDCBP and PDCD6IP . Able to induce its own expression in dental mesenchymal cells and also in the neighboring dental epithelial cells via an MSX1-mediated pathway (By similarity). . |
Accessions | ENST00000254351.9 ENST00000381150.5 E9PHH3 ENST00000403076.5 F8WCX9 H7C1K4 ENST00000429035.1 ENST00000447124.1 P18827 |